Drug
Xaluritamig
Xaluritamig: highest development phase Phase 1, developed by Amgen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Amgen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Xaluritamig NCT07297979 | Phase 1 | Ewing Sarcoma |
Latest
No recent events.
Follow Xaluritamig on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.